The Best Place for IVF Gender Selection in Egypt

Are you exploring IVF gender selection and wondering whether it is possible to identify an embryo’s sex before pregnancy?

Advances in reproductive medicine allow certain genetic characteristics of embryos to be identified before transfer through preimplantation genetic testing (PGT). In suitable circumstances, this information may be used to select an embryo according to its chromosomal sex, subject to the applicable laws, clinical policies and ethical requirements.

Pyramedicine helps international patients explore IVF gender selection options in Egypt, understand the treatment pathway and coordinate enquiries about fertility care.

Whether you are researching family balancing, investigating fertility treatment abroad or considering IVF with genetic testing, it is important to understand what the process involves, what it can and cannot guarantee, and what costs you should expect.

This guide covers how gender selection IVF works, the role of PGT, treatment costs, success rates, eligibility and practical considerations for patients travelling from the UK, Saudi Arabia, the UAE, Qatar and other countries.

What is IVF gender selection?

IVF gender selection, more accurately called sex selection, refers to selecting an embryo for transfer based on its chromosomal sex as identified through embryo genetic testing.

The process generally involves:

1. Undergoing in vitro fertilisation (IVF).
2. Allowing fertilised eggs to develop into embryos in the laboratory.
3. Performing preimplantation genetic testing where appropriate.
4. Reviewing the results with the fertility team.
5. Considering an embryo for transfer in accordance with the treatment plan and applicable regulations.

The distinction between sex and gender is important. Genetic testing can identify certain chromosomal characteristics associated with biological sex; it does not determine a future child’s gender identity.

Gender selection is not a separate fertilisation technique. It is a potential use of information obtained through embryo testing during an IVF treatment cycle.

Its availability for nonmedical reasons varies by jurisdiction and clinic. Patients should confirm the applicable rules and the treating clinic’s policy before making financial or travel commitments.

How does gender selection IVF work?

The exact treatment plan depends on your medical history, ovarian reserve, fertility diagnosis and the clinic’s protocol.

Step 1: Initial fertility consultation

The fertility specialist reviews your reproductive history and determines whether IVF is appropriate.

The assessment may include:

• Your age and medical history.
• Ovarian reserve testing, including AMH where indicated.
• Ultrasound assessment of the ovaries and uterus.
• Relevant hormone and other blood tests.
• Semen analysis, where applicable.
• Previous fertility treatment and pregnancy history.
• Discussion of the reason for requesting embryo sex selection.

Your specialist should explain the potential benefits, limitations, risks and alternatives before treatment begins.

Step 2: Ovarian stimulation

If IVF is appropriate, medication may be prescribed to stimulate the ovaries to develop multiple follicles.

The medication protocol depends on your circumstances and may involve injectable hormones and other medicines. Ultrasound scans and, where indicated, blood tests monitor the response.

Not every patient responds in the same way, and the number of eggs collected cannot be guaranteed.

Step 3: Egg collection and fertilisation

Once the follicles are ready, eggs are collected in a clinical procedure.

The eggs are then fertilised with sperm in the laboratory. This may involve conventional IVF or intracytoplasmic sperm injection (ICSI), depending on the clinical indication and laboratory plan.

The resulting embryos are monitored as they develop.

Step 4: Embryo development and genetic testing

Where appropriate, embryos may be cultured to the blastocyst stage before a small sample of cells is taken for genetic testing.

The laboratory analyses the sample according to the type of PGT requested. Depending on the test, the results may provide information about chromosome number, chromosomal sex or specific inherited genetic conditions.

Not every embryo will reach the stage required for testing. Some embryos may not produce a conclusive result, and not every tested embryo will be suitable for transfer.

Step 5: Reviewing embryo results

The fertility specialist discusses the results with you, including which embryos have results considered suitable for the intended treatment.

Where embryo sex has been reported, whether and how that information can be used in embryo selection depends on the clinical indication, local rules and clinic policy.

It is important to understand that a result identifying chromosomal sex does not establish that an embryo is free from every genetic condition or guarantee a successful pregnancy.

Step 6: Embryo transfer

An embryo considered appropriate for transfer may be placed into the uterus according to the treatment plan.

Some patients have a fresh transfer, while others have a frozen embryo transfer. The decision depends on factors such as the testing process, embryo development, endometrial preparation and the clinical team’s recommendation.

A successful transfer does not guarantee implantation, pregnancy or live birth.

What is PGT, and how does it help with gender selection?

Preimplantation genetic testing (PGT) is a broad term for genetic testing performed on cells taken from embryos created through IVF.

There are different forms of PGT, and they have different purposes.

PGT-A may provide information about chromosomal sex while assessing chromosome copy number. PGT-M is used when there is a known genetic condition that can be tested for, while PGT-SR addresses specific structural chromosome abnormalities.

These tests are not interchangeable, and the appropriate test depends on the medical indication and treatment goals.

Does PGT guarantee a healthy baby?

No. PGT can provide valuable information, but it has limitations.

A result may not detect every genetic or developmental problem. Testing is based on a sample of cells and may not fully represent every cell in the embryo. False-positive, false-negative, inconclusive or other complex results can occur.

PGT-A also does not guarantee implantation, pregnancy or live birth, and it is not appropriate or beneficial for every IVF patient.

Ask the fertility specialist to explain which test is proposed, why it is being recommended, what it can detect and what uncertainty remains.

How accurate is IVF gender selection?

When an embryo has a clear, reportable chromosomal result from a validated genetic testing process, the result can provide highly reliable information about chromosomal sex. However, no medical test should be described as infallible.

It is important to distinguish between three separate questions:

• Can the test identify chromosomal sex? A suitable genetic test may provide this information.
• Will an embryo of the selected sex be available? This depends on how many embryos develop, their test results and their suitability for transfer.
• Will the transfer result in a baby? This depends on many factors, including embryo development, age, uterine factors and individual clinical circumstances.

The accuracy of embryo sex identification is not the same as the chance of achieving a live birth.

If selecting a particular sex is central to your treatment goals, ask the clinic what happens if no suitable embryo of the requested sex is available. You should understand the options before beginning treatment.

What is the success rate of IVF gender selection?

There is no single success rate that applies to everyone undergoing IVF with gender selection.

Outcomes depend on several factors, including:

• Age at the time of egg collection.
• Ovarian reserve and response to stimulation.
• Number of eggs collected.
• Fertilisation and embryo development.
• Number of embryos suitable for testing.
• Genetic testing results.
• Embryo quality and clinical suitability.
• Uterine and other reproductive factors.
• Whether the outcome measured is pregnancy or live birth.

A patient may have a high probability of obtaining information about the chromosomal sex of a suitable tested embryo but a different probability of achieving a live birth.

Ask the clinic to distinguish between:

• The likelihood of obtaining embryos suitable for testing.
• The proportion of tested embryos with a particular chromosomal sex.
• The likelihood of having an embryo suitable for transfer.
• Pregnancy rates per transfer.
• Live birth rates per embryo transfer or per treatment cycle started.

These figures measure different outcomes and should not be treated as interchangeable.

No clinic can guarantee a particular embryo sex will be available or that a pregnancy will result.

How much does IVF gender selection cost in Egypt?

The total cost depends on the IVF protocol, medication, laboratory services, genetic testing and the services included in the clinic’s package.

For patients travelling internationally, flights, accommodation, local transport and follow-up arrangements may also affect the total budget.

Pyramedicine charges an additional fee of around US$1,000 for gender selection alongside IVF. The actual total depends on the treating clinic’s current prices, the testing required and the treatment plan.

What affects the cost?

Is gender selection IVF cheaper in Egypt than in the UK?

Costs vary between providers, and an accurate comparison requires equivalent treatment packages.

When comparing options, look beyond the headline IVF price. Confirm whether the quoted amount includes genetic testing, medication, embryo freezing, transfer and any additional consultations.

You should also account for travel, accommodation, time away from work and the possibility that treatment may require more than one visit.

Pyramedicine can help you enquire about current IVF and genetic testing costs in Egypt and clarify which services are included in the proposed package.

Can you choose a boy or a girl with IVF?

Embryo testing may identify chromosomal sex, allowing a clinic to discuss embryo selection where this is permitted and clinically appropriate.

However, several factors determine what is possible:

• Whether IVF produces embryos that develop sufficiently for testing.
• The results of genetic testing.
• Whether an embryo is considered suitable for transfer.
• The applicable legal and regulatory requirements.
• The clinic’s policy on sex selection for medical and nonmedical reasons.

The expected sex ratio of embryos is not a guarantee that a particular cycle will produce an embryo of the requested sex.

If your treatment goal is to have a boy or a girl, ask the clinic to explain what happens if the cycle does not produce a suitable embryo of the requested sex. You should also discuss whether any embryos not selected for transfer may be stored and what options are available for their future use.

Is IVF gender selection legal in Egypt?

This is an important question to resolve before booking treatment.

The availability of sex selection depends on the applicable laws, regulations, medical indications and clinic policies. Rules can differ between countries, and a clinic’s willingness to discuss a treatment should not be treated as proof that every form of sex selection is legally permitted.

For nonmedical reasons, sex selection is ethically controversial. The American Society for Reproductive Medicine (ASRM) states that clinics may develop policies on whether to offer nonmedical sex selection and emphasises informed consent and safeguards against coercion.

Patients considering treatment in Egypt should obtain confirmation from the treating clinic about the current legal and regulatory position, whether the intended indication is permitted and which procedures can be offered in their circumstances.

If the purpose is to avoid a serious sex-linked genetic condition, explain this to the specialist because the clinical and ethical considerations may differ from selection for family balancing.

Before paying a deposit or booking travel, obtain clear confirmation of the treatment’s availability and the basis on which it will be offered.

Medical sex selection vs family balancing

Not all requests for embryo sex selection have the same purpose.

Medical sex selection

In some families, a known inherited condition is linked to sex chromosomes. Genetic counselling and appropriate testing may help assess the risk of passing on a particular condition and identify relevant reproductive options.

The appropriate approach depends on the specific condition and its inheritance pattern. PGT-M may be relevant when testing for a known disease-causing variant, while other approaches may be considered depending on the circumstances.

Patients should receive genetic counselling and understand the limitations of testing.

Family balancing

Family balancing generally refers to seeking a child of a particular sex because of the sex of existing children or personal family preferences.

This is different from preventing transmission of a serious inherited condition. Nonmedical sex selection raises ethical concerns and may be restricted by law or clinic policy.

If you are considering family balancing, ask the provider whether it is permitted in your circumstances and what ethical, clinical and regulatory requirements apply.

Who may be suitable for IVF gender selection?

Suitability depends on whether IVF is clinically appropriate, the patient’s reproductive health and the treatment being considered.

An initial consultation should assess:

• Age and reproductive history.
• Ovarian reserve and likely response to medication.
• Uterine health and relevant medical conditions.
• Sperm factors, where applicable.
• Previous IVF cycles and outcomes.
• The reason for requesting embryo genetic testing.
• Whether the requested treatment is legally and clinically available.

Some patients may not produce embryos suitable for testing or transfer. Others may obtain embryos, but none may meet the criteria required for the intended treatment.

The fertility specialist should explain the likely treatment pathway, alternatives and costs before you make a commitment.

What are the risks of IVF with gender selection?

IVF with embryo testing involves the risks and limitations of IVF, with additional considerations related to genetic testing and embryo selection.

Potential risks and burdens include:

• Side effects of ovarian stimulation medication.
• Ovarian hyperstimulation syndrome (OHSS).
• Risks associated with egg collection and anaesthesia or sedation.
• No embryos developing to a stage suitable for testing.
• Inconclusive or unexpected genetic testing results.
• No embryo suitable for transfer.
• Failure of implantation or miscarriage.
• No live birth despite treatment.
• Financial and emotional costs if further cycles are required.

Embryo biopsy is designed to obtain a sample while minimising harm, but it is not entirely risk-free. The treating team should explain the laboratory’s approach and the limitations of testing.

Patients should also consider the implications of storing embryos, deciding which embryos to transfer and making plans for embryos that are not selected.

IVF gender selection for patients travelling from the UK and Gulf

International patients may need to coordinate medical investigations, travel dates, accommodation and the timing of treatment.

If you are travelling from the UK, Saudi Arabia, the UAE, Qatar, Kuwait or elsewhere, consider the following before booking.

Before you travel

• Ask whether your existing fertility records can be reviewed remotely.
• Confirm which investigations must be completed before arrival.
• Obtain a written, itemised quotation.
• Ask which genetic test is proposed and why.
• Confirm the legal and clinical availability of the intended treatment.
• Clarify how many visits may be needed.
• Ask how long you should expect to stay in Egypt.
• Discuss what happens if your ovarian response or treatment timeline changes.
• Confirm the plan for embryo freezing and later transfer, if applicable.
• Agree on follow-up arrangements after returning home.

IVF timelines are individual and can change during treatment. Avoid making non-refundable travel plans until the clinic has explained the likely schedule and the flexibility required.

Pyramedicine can help you enquire about fertility care in Egypt and clarify practical arrangements for international patients. The treating fertility specialist remains responsible for assessing medical suitability and recommending treatment.

Why explore IVF gender selection with Pyramedicine?

Choosing fertility treatment abroad requires careful planning and clear information. Patients need to understand the proposed procedure, the laboratory testing involved, the likely costs and the arrangements for follow-up.

Pyramedicine helps international patients explore fertility treatment options in Egypt and navigate the process of arranging care.

Depending on the provider and package, support may include:

• Enquiries about consultation and treatment availability.
• Information about IVF and embryo genetic testing.
• Clarification of current package prices and exclusions.
• Assistance coordinating appointments.
• Guidance on travel and accommodation arrangements, where available.
• Clarification of the next steps for international patients.

All medical recommendations, treatment decisions and informed consent remain the responsibility of the treating fertility team.

Before proceeding, patients should receive clear information about the treatment’s legal availability, risks, alternatives and realistic outcomes.

Frequently asked questions about IVF gender selection in Egypt

1. What is IVF gender selection?

IVF gender selection, more accurately described as sex selection, involves using information from embryo genetic testing to select an embryo for transfer according to its chromosomal sex, where permitted and appropriate.

2. How does gender selection IVF work?

The process usually involves ovarian stimulation, egg collection, fertilisation, embryo development and genetic testing. The results are reviewed with the fertility specialist before an appropriate embryo is considered for transfer.

3. Is gender selection IVF available in Egypt?

Patients can enquire about available options through Pyramedicine. The exact treatment that can be offered depends on current legal and regulatory requirements, clinical circumstances and the treating clinic’s policy. Confirm these details before booking.

4. How much does gender selection IVF cost in Egypt?

Costs depend on the IVF package, medication, genetic testing, embryo freezing, transfer and other services. Pyramedicine uses an indicative additional gender-selection fee of around US$1,000, but current pricing and the total package cost must be confirmed directly.

5. Is IVF gender selection 100% accurate?

Genetic testing can provide highly reliable information about chromosomal sex when results are clear and the test is appropriately performed. However, no test should be described as infallible, and identifying chromosomal sex does not guarantee pregnancy or live birth.

6. Does PGT guarantee a healthy baby?

No. PGT can identify certain genetic or chromosomal findings but cannot rule out every genetic condition, developmental problem or pregnancy complication.

7. Can I choose a boy or a girl?

Embryo testing may identify chromosomal sex, but selection depends on the availability of suitable embryos, applicable law, clinical indications and clinic policy. A particular sex cannot be guaranteed to be available in every cycle.

8. Is gender selection the same as PGT-A?

No. PGT-A assesses chromosome copy number, and chromosomal sex may be reported as part of the result. Gender selection describes a potential use of embryo sex information; PGT-A has a broader testing purpose.

9. Is gender selection IVF safe?

IVF and embryo testing involve medical risks and limitations. A fertility specialist should explain the risks of ovarian stimulation, egg collection, embryo biopsy and treatment failure, alongside the alternatives available.

10. Can international patients arrange gender selection IVF in Egypt?

International patients can enquire about treatment options and travel arrangements through Pyramedicine. They should confirm legal availability, clinical suitability, treatment timing, costs and follow-up requirements before making travel commitments.

Enquire about IVF gender selection in Egypt with Pyramedicine

If you are exploring IVF gender selection, the first step is to understand the available options and establish whether the intended treatment is appropriate and permitted in your circumstances.

A fertility consultation can help you understand the role of embryo testing, the limitations of genetic results, the likely costs and the practical arrangements involved in treatment abroad.

Pyramedicine can help you enquire about IVF and fertility treatment options in Egypt, clarify package information and coordinate the next steps.

Contact Pyramedicine to enquire about current IVF gender selection options, treatment costs and support for international patients.

Your decision should be based on accurate information, a personalised clinical assessment and a clear understanding of the potential benefits, risks and limitations.